Interlaboratory variability in fluorescence in situ hybridization analysis

被引:13
|
作者
Moore, DH
Epstein, L
Reeder, J
Wheeless, L
Waldman, FM
Aamodt, R
CordonCardo, C
Fradet, Y
Grossman, B
Hemstreet, G
机构
[1] NCI,BETHESDA,MD 20892
[2] MEM HOSP,NEW YORK,NY
[3] UNIV LAVAL,QUEBEC CITY,PQ,CANADA
[4] ANDERSON MED CTR,HOUSTON,TX
[5] UNIV OKLAHOMA,MED CTR,OKLAHOMA CITY,OK
[6] UNIV ROCHESTER,ROCHESTER,MI
来源
CYTOMETRY | 1996年 / 25卷 / 02期
关键词
fluorescence in situ hybridization; variability; bladder cancer; chi(2); multinomial distribution;
D O I
10.1002/cyto.990250202
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Reliable interpretation of fluorescence in situ hybridization (FISH) data, especially data that have been generated in more than one laboratory, requires knowledge of the sources of variability inherent in FISH analysis, Possible sources of variation may derive from differences in sample preparation, probes used, intrasample heterogeneity, hybridization protocols, counting criteria within and between scorers, fluorescence microscopes, and filters. This study characterized the relative weight of some of these factors in order to determine the degree to which FISH results are comparable between laboratories, We used a hierarchical partitioned chi(2) analysis to measure sources of variation. We found that replicate counts varied no more than expected based on counting statistics (i.e., multinomial variation), However, with replicate hybridizations done in two separate laboratories, the variability increased significantly, Thus, care must be taken when interpreting FISH data that are derived from more than one institution, Previously agreed upon counting criteria as well as standardized FISH hybridization protocols may decrease this variability. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 50 条
  • [1] Fluorescence In Situ Hybridization Analysis of Pancreatoblastoma
    Wang, Chang-Liang
    Zhao, Wen-Hua
    Yu, Jinming
    Li, Sheng
    PANCREAS, 2009, 38 (02) : 223 - 224
  • [2] Analysis of ameloblastomas by comparative genomic hybridization and fluorescence in situ hybridization
    Toida, M
    Balázs, M
    Treszl, A
    Rákosy, Z
    Kato, K
    Yamazaki, Y
    Matsui, T
    Suwa, T
    Hatakeyama, D
    Makita, H
    Mori, S
    Yamashita, T
    Shibata, T
    Adány, R
    CANCER GENETICS AND CYTOGENETICS, 2005, 159 (02) : 99 - 104
  • [3] Fluorescence in situ hybridization analysis of biomarkers in cancer
    Mark, HFL
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1999, 67 (03) : 131 - 134
  • [4] Analysis of DNA replication by fluorescence in situ hybridization
    Boggs, BA
    Chinault, AC
    METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 13 (03): : 259 - 270
  • [6] Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization
    Isola, J
    Tanner, M
    Forsyth, A
    Cooke, TG
    Watters, AD
    Bartlett, JMS
    CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4793 - 4798
  • [7] Fluorescence in situ hybridization
    不详
    NATURE METHODS, 2005, 2 (03) : 237 - 238
  • [8] Fluorescence in situ Hybridization
    Chen, Amy Y.Y.
    Chen, Andrew
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (05) : E1 - E4
  • [9] Fluorescence in situ hybridization
    不详
    Nature Methods, 2005, 2 (3) : 237 - 238
  • [10] Fluorescence In Situ Hybridization
    Tsuchiya, Karen D.
    CLINICS IN LABORATORY MEDICINE, 2011, 31 (04) : 525 - +